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a b s t r a c t
Mutations in the Pax6 gene cause ocular defects in both vertebrate and invertebrate animal species, and
the disease aniridia in humans. Despite extensive experimentation on this gene in multiple species,
including humans, we still do not understand the earliest effects on development mediated by this gene.
This prompted us to develop pax6mutant lines in Xenopus tropicalis taking advantage of the utility of the
Xenopus system for examining early development and in addition to establish a model for studying the
human disease aniridia in an accessible lower vertebrate. We have generated mutants in pax6 by using
Transcription Activator-Like Effector Nuclease (TALEN) constructs for gene editing in X. tropicalis.
Embryos with putative null mutations show severe eye abnormalities and changes in brain develop-
ment, as assessed by changes in morphology and gene expression. One gene that we found is
downregulated very early in development in these pax6 mutants is myc, a gene involved in pluripotency
and progenitor cell maintenance and likely a mediator of some key pax6 functions in the embryo.
Changes in gene expression in the developing brain and pancreas reﬂect other important functions of
pax6 during development. In mutations with partial loss of pax6 function eye development is initially
relatively normal but froglets show an underdeveloped iris, similar to the classic phenotype (aniridia)
seen in human patients with PAX6 mutations. Other eye abnormalities observed in these froglets,
including cataracts and corneal defects, are also common in human aniridia. The frog model thus allows
us to examine the earliest deﬁcits in eye formation as a result of pax6 lesions, and provides a useful
model for understanding the developmental basis for the aniridia phenotype seen in humans.
& 2015 Elsevier Inc. All rights reserved.
Introduction
The transcription factor Pax6 plays an essential role in a highly
conserved network of genes controlling eye development in both
invertebrates and vertebrates (Callaerts et al., 1997; Gehring and Ikeo,
1999). Pax6 also plays critical roles outside of the eye, in brain and
spinal cord development (Manuel and Price, 2005; Stoykova et al.,
1996) as well as in development of the pancreas and intestinal
enteroendocrine cells (Hill et al., 1999; St-Onge et al., 1997) and is
active throughout development in different phases of organogenesis
and into adult life (Osumi et al., 2008). Homozgyous mutations in
animals ranging from Drosophila (Sturtevant, 1951) to mammals
(Hogan et al., 1986; Roberts, 1967) result in eyelessness and pheno-
types in other sites of activity as well. In humans heterozygotes
develop the syndrome aniridia, so named because patients have no
iris (or a poorly formed iris), though the defect is far more pervasive
in the eye, leading to defects in the cornea, lens and retina that can
result in severe visual deﬁcits that typically increase with age
(Hingorani et al., 2012). In this study we use gene-editing tools to
generate mutations in the amphibian Xenopus tropicalis to study the
role of pax6 both in development and disease.
Study of the function of pax6 in the amphibian X. tropicalis
offers the prospect of clarifying its activity at key early stages. In
addition, as a diploid Xenopus species it is well suited to genetic
studies to examine function, and also provides the many overall
advantages of the Xenopus system (e.g. ready access to large
numbers of embryos, suitability for surgical manipulations) for
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examining early developmental phenomena (Harland and
Grainger, 2011).
Mutations in Pax6 have been discovered or induced in a number
of model organisms, providing insight into the function of this gene
from a number of perspectives. The Small eye (Sey) mutant in the
mouse is semi-dominant, resulting in heterozygotes with eye deﬁcits
(Hogan et al., 1988, 1986), including an aniridia-like phenotype
similar to that seen in humans, though in the mouse the phenotype
includes a small eye, which is not reported in human patients
(Kokotas and Petersen, 2010). Rat Small-eye mutations (rSey and
rSey2) cause a similar phenotype (Matsuo et al., 1993; Osumi et al.,
1997). Both mouse and rat Small eye mutations result in premature
stop codons. Other missense mutations in the mouse are hypo-
morphs with varying degrees of different eye abnormalities (Favor
et al., 2008, 2001). Homozgyous null mutations are lethal in mice,
with severe brain and olfactory deﬁcits (Hogan et al., 1986), and in
the rare cases of compound heterozygotes in humans most indivi-
duals die perinatally (Glaser et al., 1994).
The Pax6 gene has a complex structure and regulation (Shaham et
al., 2012) that reﬂect the many functions of this gene and which are
relevant to the mutations discussed in this study. The gene has 16
exons, and three promoters drive its expression yielding several
transcripts. Transcription is further controlled by a large number of
regulatory elements that reside both within the gene and at signiﬁcant
distances 50 and 30 of the coding region. Details relevant to this paper
are described in Fig. 1 and discussed in the Results section. This
transcription factor has the characteristic structural features of many
genes in the Pax family, including the bi-partite DNA-binding paired
domain toward the 50 end of the gene, found in all members of this
gene family. The paired domain is connected to a glycine-rich linker
bridging it to a paired-like homeodomain. At the C-terminal end of the
protein is a proline-serine-threonine (PST) domain that is essential for
the transactivation properties of Pax6. The mouse Pax6Sey mutation
described above is due to a nonsense mutation upstream of the 50 end
of the homeodomain and is presumed to be a null mutation based on
the fact that it is allelic to Dickie’s Small eye (SeyDey), which deletes the
Pax6 gene (Hogan et al., 1988) and generates an identical phenotype to
SeyDey in homozygotes. Similarly it is presumed that in human aniridia
the PAX6 gene is likewise generally a null since it presents with the
same aniridia phenotype in WAGR (Wilms tumor, aniridia, genitour-
inary abnormalities, mental retardation) syndrome that occurs
because of a chromosomal deletion that includes the PAX6 gene
(Prosser and van Heyningen, 1998).
Some embryonic gene targets of Pax6 that may result in the
numerous phenotypes described above have been studied but
signiﬁcant questions remain, particularly about the earliest
changes in targets associated with Pax6 mutations, but also those
associated with later events, including brain development and
later eye defects. In Xenopus, pax6 is activated at the late gastrula
stage in the presumptive anterior neural plate and is continuously
expressed thereafter (Hirsch and Harris, 1997), a pattern seen in
mammals as well. In the mouse, following neurulation, a member
of the Necab gene family (N-terminal EF-hand calcium binding
proteins) is downregulated in the Sey mutant but a number of key
regulatory genes important in retina and forebrain formation that
have been examined at this stage of development (e.g. the homeo-
box genes Six3, Otx2, Rax and Lhx2) were not found to be
immediate targets of Pax6 (Bernier et al., 2001). Nuclear protein
gene Mab21l1 (Yamada et al., 2003) and the secreted frizzled-
related protein gene Sfrp2 (Wawersik et al., 1999) are also down-
regulated in the Sey mutant. In a zebraﬁsh study of pax6 targets
(Coutinho et al., 2011) a number of genes are downregulated upon
morpholino antisense oligonucleotide treatment of embryos and
studies on speciﬁc differentiated tissues in the mouse, e.g. the lens,
Fig. 1. Strategy for targeted mutagenesis of Xenopus tropicalis pax6 locus. (A) Structure of pax6 gene is shown schematically (not to scale). P0, P1, Pα are promoters (shaded in
grey). Exons (boxes) are numbered or named on top (0 to 13 or α) and color coded: white, untranslated regions (UTRs); orange, N-terminal region before the paired domain;
other colors correspond to color codes for protein domains shown in (B). Two translation start sites are shown (ATG): orange, for full-length isoforms (Pax6 with or without
5a); green, for paired-less isoform (Pax6ΔPD). Positions of mouse Sey and rat rSey2 mutations are indicated by arrows on the bottom. Two pairs of TALEN targets in exon
7 and exon 9 are shown on top. (B) Structures of Pax6 wild-type and representative mutant proteins are shown schematically (not to scale). Color codes of protein domains
are shown in the box except the ﬁrst three amino acids, which are shown in orange. Note that the paired domain is located between amino acids 4–131 and the
homeodomain between amino acids 212–272 in X. tropicalis due to insertion of two amino acids between the two domains. The amino acid sequence of each domain is as
shown in Walther and Gruss (1991). Most but not all mutations have some non-Pax6 amino acids at the C-terminus. Note that X. tropicalis mutations in exon 7 could
theoretically encode Pax6ΔPD if mutations were not simultaneously introduced in exon 9 (not shown in the drawing). (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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provide a more global analysis of later Pax6 targets (Wolf et al.,
2009). However there remains very little information about the
changes in gene expression, and their effects on development, that
accompany the period just after Pax6 activation at the end of
gastrulation and during early neurula stages when important
elements in patterning of the retina and neural plate are being
established (Saha and Grainger, 1992).
The rapid progress in gene editing with TALEN and CRISPR
constructs in the past few years (Peng et al., 2014) has allowed
rapid genetic manipulations in Xenopus as in many other organ-
isms. Both TALENs (Ishibashi et al., 2012; Lei et al., 2012; Nakajima
et al., 2013; Nakajima and Yaoita, 2013) and CRISPRs (Blitz et al.,
2013; Guo et al., 2014; Nakayama et al., 2013) have generated
mutant phenotypes in a number of genes and genetically modiﬁed
lines in the case of production of albino animals mutated in the
tyrosinase gene. The study described here, in which we target the
pax6 gene with TALEN constructs, is the ﬁrst in depth study in
which F1 and/or F2 non-mosaic animals carrying putative muta-
tions in a key developmentally regulated gene have been exam-
ined using targeted gene editing in Xenopus. A previous study
described the F0 mosaic phenotype in Xenopus laevis embryos
where the pax6 gene was targeted (Suzuki et al., 2013).
In this study we ﬁnd that gene targeting of pax6 results in a
highly consistent, putative null phenotype in F1 and F2 homo-
zygote and/or compound heterozygote embryos: a severely
reduced eye which fails to form a lens. The consistent mutant
platform permits us to begin to examine gene expression changes
that accompany the initial phases of retina and brain formation
and provides a powerful starting point for elaborating the initial
functions of the pax6 gene during development. An allele was also
identiﬁed that appears to reduce but not inactivate pax6 activity,
revealing a hypomorphic phenotype in which early development
appears normal but froglets exhibit eye abnormalities very similar
to those seen in aniridia patients, providing a highly accessible
model system for studying the ontogeny leading to the aniridia
syndrome and for potentially mitigating the disease phenotype.
Materials and methods
Construction of TALENs to target the pax6 gene
TALEN scaffolds with the obligate heterodimeric FokI (ELD/KKR)
were obtained from Christopher H. K. Cheng (pCS2þTALEN-ELD/KKR;
(Lei et al., 2012). For an experimental control, we used pCSþTALEN-
ELD/KKR-Tyr I (to target the tyrosinase gene), which was described
previously (Nakajima and Yaoita, 2013), hereafter referred to as pCS-
ELD/KKR-Tyr I for simplicity. To target exon 7 and exon 9 of the pax6
gene, we chose 50-GTCATCAATAAACCGAGTGCTGCGCAACCTGGCGAGC-
GAAAAGCA-30 for exon 7 and 50TTGAACGAACACATTACCCCGACG-
TGTTTGCCAGGGAAAGATTAGCTGCC-30 for exon 9, where underlined
sequences are left targets and double-underlined sequences are right
targets (in antisense-strands). The DNA binding domains to recognize
these targets were assembled as previously described (Cermak et al.,
2011) with minor modiﬁcations as reported (Nakajima et al., 2013).
TALENs recognizing left targets were constructed in pCSþTALEN-ELD
to yield pCSþTALEN-ELD-pax6 E7 (for exon 7) or E9 (for exon 9), and
pCSþTALEN-KKR-pax6 E7 or E9 were similarly constructed for right
targets. Hereafter these are referred to as pCS-ELD/KKR-pax6 E7/E9 for
simplicity. The EMBOSS program fuzznuc (Rice et al., 2000) was used
to search for possible off-target sites of these TALENs based on the X.
tropicalis genome sequence Assembly v4.1 (Hellsten et al., 2010). Since
the repeat variable di-residue NN for recognizing the nucleotide G
could also bind to the nucleotide A, R (i.e., G or A) was used in the off-
target search of left targets and Y (i.e., C or T) in the right targets
search. Thus the off-target sites of pCS-ELD/KKR-pax6 E7 used both
the sense ‘RTCATCAATAAACCRN(10,30)GGYGAGYGAAAAGYA’ and the
antisense sequence ‘TRCTTTTCRCTCRCCN(10,30)YGGTTTATTGATGAY’,
ELD/KKR-pax6 E9 used ‘TTRAACRAACACATTN(10,30)YYAGGGAAAGAT-
TAGYTGYY’ and ‘RRCARCTAATCTTTCCCTRRN(10,30)AATGTGTTYGT-
TYAA’, and pCS-ELD/KKR-Tyr I used ‘TTCTTCTTCCTCCATRTN(10,30)
YYYAAGGGYATGTAGYA’ and ‘TRCTACATRCCCTTRRRN(10,30)AYATG-
GAGGAAGAAGAA’. Since TALENs from pCS-ELD-pax6 E7 and pCS-
KKR-pax6 E9 or pCS-ELD-pax6 E9 and pCS-KKR-pax6 E7 could make a
heterodimer when 4 TALEN mRNAs are co-injected, we also tested
combinations of the exon 7 left target and the exon 9 right
target, ‘RTCATCAATAAACCRN(10,30)YYAGGGAAAGATTAGYTGYY’ and
‘RRCARCTAATCTTTCCCTRRN(10,30)YGGTTTATTGATGAY’, as well as
the exon 9 left target and the exon 7 right target, ‘TTRAACRAACA-
CATTN(10,30)GGYGAGYGAAAAGYA’ and ‘TRCTTTTCRCTCRCCN(10,30)
AATGTGTTYGTTYAA’. We saw a few theoretically possible off-target
sites with 10 to 30 spacer nucleotides having three or more mis-
matched nucleotides, but no complete matches to off-target sites were
found in any of the combinations examined.
Xenopus tropicalis, synthesis of TALEN mRNAs and microinjection
We used in house breeding stocks of X. tropicalis, which are not
highly inbred but originated from the same ancestors of the Nigerian
inbred line that was used for genome sequencing (Hellsten et al.,
2010). X. tropicalis eggs were fertilized in vitro, dejellied, and inje-
ctions made into one cell stage embryos within 40 min after
fertilization as in earlier studies (e.g. Ogino et al., 2006). Embryos
were raised to adults as described previously (Hirsch et al., 2002).
The capped mRNAs encoding each TALEN that were injected
into embryos were synthesized from pCS-ELD/KKR-Tyr I and pCS-
ELD/KKR-pax6 E7/E9 using the mMESSAGE mMACHINEs SP6 Kit
(Invitrogen). A pair of each 100 pg or 200 pg of TALEN mRNAs for
left and right targets was mixed for injection. As for dual targeting
exon 7 and exon 9 simultaneously, two pairs of TALENs (each 100
or 200 pg) were mixed and injected.
Genotyping of pax6 and rax mutant and wild-type embryos
Since we can easily distinguish between pax6 “null” mutant
and wild-type phenotypes at tadpole stages due to different
morphologies of the eye region, we do not necessarily perform
genotyping on embryos older than st.35 [all stages according to
Nieuwkoop and Faber (1994)]. In this case, the genotype of
embryos with a wild-type appearance is designated as (þ/?). All
embryos shown at earlier stages were genotyped. Embryos were
lysed as described (Fish et al., 2012), followed by genomic PCR of
the pax6 region (PCR primers are listed in Fig. 3). The PCR
amplicon was puriﬁed and sequenced, or as needed, re-cloned
and sequenced. In most experiments, phenotypes are indistin-
guishable between þ/þ and þ/ , and thus one representative
embryo of either genotype has been chosen as a “wild-type”
exemplar to image and labeled as (þ/?) unless otherwise
described. Genotyping of rax mutant and wild-type embryos was
performed as described (Fish et al., 2014).
Tissue processing and histology
For X. tropicalis studies, to analyze mutant phenotypes,
embryos were ﬁxed overnight in Bouin’s ﬁxative and embedded
either in JB-4 Pluss resin (Polysciences) or in Paraplasts Plus.
Plastic embedded tissue was sectioned at 3 μm and stained with
toluidine blue. Parafﬁn embedded tissue was sectioned at 10 mm
and stained with hematoxylin. For assessing expression domains
of certain transcription factors following in situ hybridization,
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some embryos were supported in a clay dish and sliced with a
small scalpel.
For preparation of human corneal samples, tissues were placed
in 4% paraformaldehyde and stored at 4 1C. For mouse samples,
immediately after euthanization (CO2 and cervical dislocation),
both eyes from mice were enucleated and immersed in Davidson’s
ﬁxative (Poly Scientiﬁc R&D Corp. Bay Shore, NY) at room
temperature for 24 h. The eyes were then rinsed brieﬂy in water
and then transferred into 10% neutral buffered formalin for
storage. Mouse globes were measured (Castroviejo calipers) at
the horizontal equator using 2.5 magniﬁcation. Both mouse
globes and human corneal tissues were hand-processed and
embedded in parafﬁn wax according to the following protocol:
70% ethanol for 30 min, 3100% ethanol for 30 min, 2 xylene
for 30 min, 3100% wax (Surgipath Paraplast, Leica) for 30 min at
62 1C. For mouse eyes, 7 mm sagittal sections one quarter of the
way into the globe based on prior measurements were made using
a rotary microtome; sections from human corneas were cut at
10 mm. Sections were captured on SuperFrost Ultra Plus slides. For
routine microscopy, sections were then deparafﬁnized in two
changes of xylene, rehydrated in graded ethanol (100%, 100%,
95%, 95%, and 70%), rinsed in water, stained with 10 min each of
Gill II Hematoxylin (Surgipath™, Richmond, Il.) and Eosin (Surgi-
path™, Richmond, Il.), followed by a dehydration in graded
ethanol (70%, 95%, 95%, 100%, 100%) and then two changes of
xylene. Upon completion of staining, a coverslip was applied with
Cytoseal 60 (Richard-Allan Scientiﬁc).
In situ hybridization
Whole-mount in situ hybridization was carried out essentially
according to the procedure in Sive et al. (2000), though modiﬁed
when genotyping was required, omitting acetic anhydride and
post-color ﬁxation steps as described (Fish et al., 2014). A mini-
mum of 3 (up to 5) mutant embryos were examined by in situ
hybridization for alteration of expression of downstream genes,
showing highly consistent results. All antisense probes were
labeled with digoxigenin (Roche) and detected by BCIP/NBT
(Roche) or BM Purple (Roche). Probes for myc and pax6 were
prepared as described previously (Fish et al., 2014). mab21l1 cDNA
in pCS107 vector was obtained from The Wellcome Trust Sanger
Institute and digested with EcoRI and used as template for T7
in vitro transcription to make the probe. Probes for ins, gsx2, and
neurog2 were made from templates created by genomic PCR as
described (Fish et al., 2014). Primers used for these probes are as
follows (50 to 30 direction, underlined nucleotides indicate T7
sequences):
ins 50 primer, CCAGGACAACGAGTTGGATG
ins 30 primer, TAATACGACTCACTATAGGGAGAAGCTCTTCAGCT-
TACATTTATTTGC
gsx2 50 primer, CTGCGGCAATGTCTAGGTCT
gsx2 30 primer, TAATACGACTCACTATAGGGAGATCATGCAATGGA
ATCTCCTG
neurog2 50 primer, ACTGCCATCATTACCCGAAG
neurog2 30 primer, TAATACGACTCACTATAGGGAGAGCACAGAG
AAAGGCAACACA
Frogs
The frogs used for this study were from our colony maintained
at the University of Virginia. All procedures involving frogs were
performed in accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory animals and approved by
the University of Virginia Animal Care and Use Committee.
Mice
The mice used for this study were maintained as a Pax6Sey-Neu/þ
colony on a majority CD1 genetic background with enough
C57BL6/J to provide iris pigmentation. Wild-type (Pax6þ /þ) litter-
mates were used as controls. The genotype of each animal was
determined by PCR as previously described (Kim and Lauderdale,
2006). All experiments involving mice were conducted in strict
accordance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals and were performed with
approval and oversight of the University of Georgia Institutional
Animal Care and Use Committee.
Human tissues
Cadaveric PAX6-normal human corneoscleral tissues derived
from consented donors according to Institutional Review Board
(IRB)-approved protocols were obtained from the Georgia Eye
Bank. Aniridia tissue derived from consented donors according to
Institutional Review Board (IRB)-approved protocols were
obtained from Dr. John M. Freeman (Memphis Eye and Cataract
Associates, Memphis, TN); tissue was obtained as byproduct of
scheduled procedures.
Results
Strategy for targeted mutagenesis of Xenopus tropicalis pax6 gene
and resultant mutations
As discussed earlier, the pax6 gene locus has a complex
structure (Fig. 1A), i.e., there are three promoters (P0, P1 and Pα)
and alternative splicing events to create different mRNAs, some of
which encode the same protein(s), and others which can create
different protein(s). Translation is initiated at the ATG in exon 4, to
yield a full-length protein, or at the ATG in exon 8 to yield a
paired-less protein (Kim and Lauderdale, 2008). Although to date
only one cDNA for X. tropicalis has been reported (i.e.,
NM_001006762) which lacks the exon 5a (used in one alternative
spliced form; illustrated in Fig. 1B) and encodes a 424 amino-acid
protein, there are EST clones containing exon 5a (e.g. CR438572).
In a previous study we showed evidence that promoter α appears
to be functional in X. tropicalis (Fish et al., 2012), suggesting that in
X. tropicalis there must also be multiple versions of Pax6 mRNAs
and proteins being expressed. Widely studied mouse and rat
mutations are thought to be null mutations: the mouse Pax6
mutant Sey has a substitution in exon 8 that creates a premature
stop codon (Hill et al., 1991), and rat rSey2 has an insertion in exon
7 (Osumi et al., 1997) to create (downstream) an in-frame stop
codon (Fig. 1B). In order to create similar null mutations in
X. tropicalis and knock out the function of proteins resulting from
both start sites the following strategy was undertaken: to block or
inactivate proteins from the ﬁrst ATG (Fig. 1A), we designed a
target in exon 7 using TALENs as shown schematically in Fig. 1, and
to block all protein forms, including the paired-less protein
(Pax6ΔPD) derived from the second ATG, we also targeted exon 9.
We injected mRNAs for a pair of TALENs to target exon 7 and a
pair of TALENs to target exon 9 individually or simultaneously. We
also tested a pair of TALENs to target tyrosinase (tyr) (Nakajima and
Yaoita, 2013) as a positive control for the experimental procedure
as well as a negative control for morphological phenotypes that
may be caused by the injection of any TALENs. Since our ultimate
purpose was to establish mutant lines, we did not necessarily
score F0 embryos systematically. However, at both doses we tested
(100 pg or 200 pg of each TALEN mRNA), we observed morpholo-
gically abnormal eyes in pax6 TALENs-injected embryos (Fig. 2).
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The most frequent eye phenotype seen at tadpole stage is a
horseshoe-shaped retina as seen from a lateral view, i.e., the
ventral part of the eye is not formed (Fig. 2B and D). Although
F0 animals sometimes had more severely degenerated eyes
(Fig. 2A, lateral view), this degree of abnormality was not seen in
F1 non-mosaic mutant animals (F1 mutants will be described in
more detail later). Another interesting feature of mutants apparent
when viewing animals from the dorsal aspect was a variable
disturbance of the transformation of the initially broad connection
between the brain and optic vesicle/cup, i.e. the optic stalk, into
the optic nerve. In some, but not all, phenotypic F0 animals the
optic stalk would persist in the form of a broad, cone-shaped
extension of the retinal tissue spanning part (Fig. 2A0, left eye), or
all (see example in Fig. 5 for F1 animals), of the distance between
the eye and the brain. By contrast, tyr TALENs-injected embryos
had eyes with variably reduced pigmentation which were other-
wise morphologically normal as expected (Fig. 2C).
It is important to note that the dual targeting of exons 7 and
9 simultaneously can, in addition to creating deletions within
exon7 or exon 9, create 10-kbp inversions or deletions between
exons 7 and 9. This was demonstrated by a genomic PCR assay
using different combinations of primer sets to amplify each exon,
making it possible to detect deletions spanning exon 7 and 9 and
inversions of the region between exon 7 and 9 (see Fig. 3A and B).
We further focused on examining the 10-kbp deletion event by
cloning and subsequent sequencing of genomic-PCR fragments to
verify the existence of this large deletion, demonstrating that both
pairs of TALENs had indeed cut simultaneously resulting in the
large deletion (Fig. 3C). Although we did not sequence other PCR
fragments individually from other F0 embryos, this result
suggested that small indels in exon 7 and/or exon 9, and 10-kb
inversions were likely occurring in many mosaic F0 embryos
injected with both pairs of TALENs, which we conﬁrmed in F1
animals (see below). Embryos (injected with both exons 7/9
TALENs together and exon 9 TALENs alone) that had abnormal
eyes but which were otherwise normal in appearance were sorted
and raised to adults (Fig. 2E) to establish F0 populations. We
hypothesized that animals with an abnormal or missing eye would
likely be mosaics with a high level of mutations in part of the
animal but which were viable because other regions were either
wild-type or had non-lethal (heterozygous) mutations. The stock
716 population (st.716) is comprised of F0 frogs targeting both
exons 7 and 9, and the st.718 population targets exon 9 alone.
Germline transmission of mutations and establishment of lines
carrying pax6 gene mutations
Germline transmission of mutations in mosaic F0 frogs was
evaluated by generating F1 animals from matings of F0 adults (as
illustrated in Fig. 2E). In crosses of these F0 frogs we observed
mutant phenotypes in the resulting compound heterozygote F1
animals, as described in more detail below, similar to what we saw
in F0 animals, verifying germline transmission of the mutations.
We then systematically outcrossed F0 frogs with wild-type frogs to
assay for germline transmission frequencies and allelic variation.
All six of the st.716 frogs tested had germline transmission at
various frequencies (notably, male frog #3 had 100% germline
transmission of mutations), whereas only three out of seven st.718
frogs tested had germline transmission. The mutation proﬁles and
their frequencies are summarized in Supplementary data Table S1.
Fig. 2. Representative phenotypes of F0 embryos injected with TALENs. Lateral (A and B) and dorsal (A0 , the same embryo shown in A) views of two embryos injected with a
pair of TALENs targeting pax6 exon 9 (200 pg mRNA each). Asterisks in (A) and (A0) indicate the same abnormal eye. The most frequently seen eye phenotype is shown in (B)
(arrow). (C) Lateral view of an embryo injected with a pair of TALENs targeting tyr (200 pg mRNA each). The eye is morphologically normal but less pigmented (arrow).
(D) Lateral view of an embryo injected with two pair of TALENs targeting pax6 exons 7 and 9 (200 pg mRNA each). The abnormality here (arrow) is similar to what is shown
in (B). (E) Mating of mature frogs raised from embryos injected with two pairs of pax6 TALENs. Eyes are missing in one side of each animal (arrows).
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To date, we have not yet conﬁrmed germline transmission of 10-
kbp deletions between exons 7 and 9, but we have conﬁrmed at
least one 10-kbp inversion between exons 7 and 9. Others are
small (up to 17-bp deletion) indels created in exon 7 or exon
9 alone, or simultaneously in both exons, which in many cases
cause frameshifts, resulting in premature stop codons. The pre-
dicted protein products are schematically shown in Fig. 1B (bot-
tom). As a consequence, such mutations in exon 7 encode proteins
truncated after amino acid positions between 125 and 128
depending on the individual mutation, thus lacking a few amino
acids at the end of the paired domain (that is located between
amino acid residues 4–131) and the remainder of the coding
sequence. Exon 7 mutants could still theoretically encode the
Pax6ΔPD isoform if mutations were not simultaneously intro-
duced in exon 9. Out-of-frame mutations in exon 9 encode
proteins truncated after amino acid positions between 236 and
239 depending on the individual mutation, thus lacking amino
acids after the middle of the homeodomain (located betw-
een amino acid residues 212–272). As we describe below, these
mutations seem to behave as null mutations and the proteins, if
they are expressed, do not seem to be functional.
In some cases, small indels created in-frame deletions of [3n]
bp to result in 1–5 amino-acid deletions without changing the
remainder of the protein. In case of exon 7, 1 to 5 amino acid
deletions are found in the region between 125 and 129 of the
paired domain, whereas in exon 9, one case shows a deletion of
amino acid 238 in the homeodomain. We do not know at this time
if one amino acid deletion due to the in-frame exon 9 mutation has
any impact on the mutated protein function. However, we do see
an impact of small in-frame deletions in exon 7 on the resultant
protein, discussed in detail below.
Several outcrossed F1 animals were raised to adults, establish-
ing F1 heterozygous frogs that have small indels in either exon 7 or
9, or in both, and one F1 heterozygous frog that has a 10-kb
inversion between exons 7 and 9. Both F0 and F1 mutant carriers
are used in this study. Several F2 lines are now being raised for
future study.
Consistent phenotypes are seen in mutants with premature stop
codons in exon7, or combinations of mutations in exon 7 and exon 9
The various induced pax6 mutations leading to frameshifts and
resulting in premature stop codons are expected to abrogate gene
activity, particularly the exon 7 target site. As expected we ﬁnd
that there is a consistent phenotype in compound heterozygous or
homozygous frameshift mutations in exon 7. But in addition we
see an identical phenotype in all combinations examined of
compound heterozygotes involving exon 7 and exon 9 out-of-
Fig. 3. Strategy for screening mutations in the pax6 locus edited by two pairs of TALENs targeting exon 7 and exon 9 simultaneously. (A) Schematic drawing of targeting
regions, only showing exon 7 (blue) and exon 9 (magenta) for simplicity (not to scale). Small colored arrows indicate different primers for genomic PCR of exon 7 and exon 9
(each sequence is shown on the bottom, from 50 to 30). Different combinations of primers can amplify other possible junction regions created by deletion or inversion
between exons 7 and 9 as schematically shown. (B) A representative gel pattern of genomic-PCR bands from an embryo injected with both pairs of TALENs mRNAs. In this
speciﬁc case, one of the possible junctions representing a 30 inversion site (where a 30 piece of exon 7 would have been fused inverted to 30 piece of exon 9, lane 5) was not
detected, but in other cases, we have seen such a band. (C) The genomic-PCR band corresponding to what is shown in lane 2 in (B) from 3 pooled embryos was gel-puriﬁed,
cloned, and sequenced. The results of 6 clones are aligned. Only regions between two target sites (target-Ls, left target; target-Rs, right target in orange) are shown.
Corresponding wild-type sequences are shown on top for exon 7 and on the bottom for exon 9. Multiple 10-kb deletion events were conﬁrmed, and junctions where 50 parts
of exon 7 (blue) fused to 30 parts of exon 9 (magenta) were seen in the expected cleavage regions (in between left and right targets, indicated by scissors) in both exons 7 and
9, suggesting that 10-kbp deletions were due to cleavages by TALENs and thus both TALENs were functional. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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frame mutants. Thus we hypothesize that both exon 7 and exon
9 mutations (and exon 7/9 deletions and inversions) yield inactive
Pax6 protein. Fig. 4 (stage 38–41) and Fig. 5 (stage 42 and 47)
summarize pax6 mutant phenotypes of tadpoles from different
matings of F0 and F1 mutant carrier frogs. The features of mutant
embryos are consistent in any pax6 mutant regardless of whether
they are homozygous mutants that have the 13-bp deletion in
exon 7 or compound heterozygous mutants, and regardless of
whether mutations are in exon 7 or exon 9.
The ﬁrst sign of a morphological phenotype in the mutant can
be detected between late stage 20’s to early stage 30’s, but in some
cases at such stages the phenotype is hard to distinguish from
normal morphological variation in wild-type embryos (data not
shown). The mutant phenotype becomes more obvious when
pigmentation of the retinal pigment epithelium (RPE) is com-
pleted, i.e., at late stage 30’s to early 40’s. Surprisingly, pax6
mutants in X. tropicalis, unlike Pax6 mutants in mouse Sey (Hill
et al., 1991) or rat rSey2 (Osumi et al., 1997) do not lose the eye
completely, i.e., there is a persistent eye-like structure with an
abnormal retina and no lens. As of stage 38–41 (Fig. 4), the mutant
eye has a characteristic appearance showing the RPE only in the
region corresponding to the anterior–dorsal side of the wild-type
eye, and has a highly disorganized retina and no lens as seen in
histological sections (Fig. 4E). As development proceeds (Fig. 5),
the RPE acquires a ﬂattened or arc shape because morphogenesis
of the ventral optic cup fails (Fig. 5A and C, lateral views of
mutants and Fig. 5E and F, transverse sections), a feature which
was also observed in F0 mosaic embryos (Fig. 2B and D). In some
cases, the RPE extends along the persistent optic stalk (Fig. 5A, B
and C0, orange arrows) that contains differentiated retina tissue
(Fig. 5E, red arrowhead).
Given that the rodent Pax6mutations that are similarly positioned
to our frog mutations result in no or non-functional proteins
(Engelkamp et al., 1999; Numayama-Tsuruta et al., 2007), it seems
unlikely that the truncated protein(s) in the X. tropicalis mutants, if
expressed at all, would be sufﬁciently functional to account for the
Fig. 4. Xenopus pax6 mutants have abnormal eyes without lenses. (A–D) Offspring from crosses between F0 mosaic mutation carriers (A) or F1 carriers (B–D) showed a
consistent phenotype in the eye (red arrows) regardless of the genotype of mutant alleles. F0 crosses (st.716 female #2 x male #3) created a variety of combinations of
genotypes in mutant offspring (A), whereas 25% of offspring from F1 crosses (i.e., parents are not mosaic) have a single homozygous (B) or compound heterozygous (C,D)
mutant genotype as expected. Note that mutants homozygous for a 13-bp deletion in exon 7 (B) are indistinguishable from other compound heterozygous mutants,
regardless of the combination of exon 7 mutations (A, top right embryo), combination of exon 7 and exon 9 mutations (A, bottom right embryo and D), or combination of
exon 9 mutations (C). Each embryo shown here was genotyped except for phenotypic wild-type embryos in C and D, thus shown as þ/?. Judging from the mutation proﬁles
(see Table S1), we could infer the origins of mutated alleles of offspring from F0 crosses, or in the case of F1 crosses, the genotypes of parents are known in advance, thus we
show offspring genotypes in order of parental female locus/male locus except for the top wild-type embryo in (B), where the parental origin of alleles is undeterminable.
Actual sequences of mutations can be found in Table S1. (E) Cross sections of embryos marked by red (mutant) and green (wild-type) asterisks in (A) to show morphology of
the eyes. The wild-type embryo (green asterisk) has a lens (white arrowhead) and the retina is surrounded by retinal pigment epithelial (RPE) and separated from the brain
(green arrowhead), whereas the mutant embryo (red asterisk) has no lens and the retina is disorganized (black arrowhead) and still connected to the brain (red arrowhead).
(F) Schematic presentation of proteins encoded by the mutations shown here. Also refer to Fig. 1 for color codes. Exon 7 mutations cause truncation at the C-terminus of the
paired domain (located between amino acid residues 4–131), whereas exon 9 mutations cause truncation in the middle of the homeodomain (located between amino acid
residues 212–272). Truncations in many cases but not all are followed by unrelated amino acids due to the frameshift. Note that mutant embryos shown in (C) make almost
identical mutant proteins with only one amino acid change at position 238, thus this is very close to being a homozygous mutation. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
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incomplete loss of eyes that we see. Rather, there is another
possibility that a second pax6-related gene, pax6.2, may have
redundant function in Xenopus embryos and may partially rescue
pax6 mutations. It was recently discovered that non-mammalian
vertebrates all appear to have this second pax6-like gene and that the
gene has been lost in birds and mammals (Ravi et al., 2013).
X. tropicalis Pax6.2 (XM_004912020) consists of 281 amino acids
and has 85% amino-acid identity with the region of amino acids 137–
424 of X. tropicalis Pax6. It consists of the homeodomain and PST but
no paired domain, as is characteristic of all pax6.2 genes. To assess
the possible overlapping role of pax6.2 with pax6, we examined its
expression by in situ hybridization (see Fig. S1). At early stages the
expression is not detectable by in situ hybridization, but by stage 25 a
low level of expression is detected in the dorsal half of the retina, and
becomes more obvious at later stages. Expression at later stages is
also seen in the notochord (pax6 is not expressed in this tissue), and
no expression is detected in the brain (again, unlike pax6). The pax6.2
expression domain in the retina is coincident with the dorsal location
where the partial retina is formed in pax6 mutants, consistent with
the possibility of involvement of pax6.2 in ameliorating the pax6
mutant phenotype in frog compared to mammals. Although evalua-
tion of function of pax6.2 in pax6 mutants remains to be studied in
the future, since all homozygous and compound heterozygous out-
of-frame mutants involving exon 7 and 9 deletions show consistent
phenotypes, at present we consider those phenotypes to result from
in-frame, premature stop codons caused by indel-generated frame-
shifts (see Table S1) leading to protein products with no activity.
These “null” mutant embryos at later stages have some axial defects
(data not shown) and eventually die some time after stage 46. In the
following analyses of the “null” phenotypes, we do not distinguish
different mutated genotypes but simply regard embryos as falling
into two classes: (1) frameshift mutations causing a premature stop
codon (and a clear, consistent, embryonic phenotype); or (2) “wild-
type” embryos with a normal appearance (but which may carry
cryptic mutations).
Expression of genes downstream of pax6 at early and late stages
during tadpole development
We have examined expression levels of several marker genes
that are expressed in the same tissues and organs as pax6 by in situ
hybridization. Although more extensive studies will be performed
in the future using homozygous mutant lines, in this initial study
we focus on only a few genes. Mab21l1 is a known downstream
gene of Pax6 and has important roles in eye development (Yamada
et al., 2003). As expected and consistent with the report in mouse
Pax6 mutant (i.e., Sey/Sey (Yamada et al., 2003)), we also observed
a reduction of expression of mab21l1 in “null” pax6 mutant frog
embryos (Fig. 6A). We also tested myc expression that is known to
be downstream of the key eye gene rax in the retina region (Fish et
al., 2014) as shown in Fig. 6C, but has not been identiﬁed as a
downstream target of pax6 to our knowledge. We found that myc
expression in pax6 “null” mutant is indeed downregulated speci-
ﬁcally in the regions where its expression overlaps with pax6
(Fig. 6B), i.e., the retina and brain (red arrows) and presumptive
lens ectoderm (PLE) at stage 15 (dotted white circles, Fig. 6D
Fig. 5. Phenotypes of Xenopus pax6 mutants at tadpole stages. (A) Phenotypes of F2 embryos at stage 42 from an intercross of F1 heterozygotes carrying a 13-bp deletion in
exon 7. / , homozygous mutant; þ/ , heterozygous; þ/þ , wild-type. These are siblings of embryos shown in Fig. 4B. (B) Phenotypes of F2 embryos at stage 47 from cross
between an F1 female carrying a 1-bp deletion ( #2) in exon 9 and an F1 male carrying a 13-bp deletion in exon 7.  / , compound heterozygous mutant (genotype is ex9
Δ1-bp#2/ex7 Δ13-bp); þ/ , heterozygous (genotype, þ/ex7 Δ13-bp); þ/þ , wild-type. These are siblings of embryos shown in Fig. 4D. (C and C0) Phenotype of F2 embryos
at stage 42 (C) and stage 47 (C0) frommating of an F1 female carrying a 1-bp deletion (#2) in exon 9 and F1 male carrying a 1-bp deletion (#3) in exon 9. Embryos shown in C
(mixture of lateral and dorsal views) are the same embryos as shown in C0 (all dorsal views) at the same axial position, the only difference being their ages. / , compound
heterozygous mutant (genotype is ex9 Δ1-bp#2/ex9 Δ1-bp#3); þ/ , heterozygous wild-type (genotype, ex9 Δ1-bp#2/þ for top embryo, þ/ex9 Δ1-bp#3 for second
embryo); þ/þ , homozygous wild-type. These are siblings of embryos shown in Fig. 4C. Orange arrows show the eye fused to the brain, which is often, but not always, seen in
pax6 mutants regardless of genotype. (D–F) Cross sections of the eye region of embryos shown in (B) and (C0). Corresponding embryo and section are marked by the same
colored asterisks. Wild-type embryos (D) have well organized retina and lens (white arrowhead), whereas mutants (E and F) do not have lens and the retina is disorganized
(black arrowheads). By this stage, mutant eyes were separated from the brain in some embryos (F) or still connected to the brain in other embryos (E, red arrowhead). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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shows both expression of pax6 and myc in the PLE). This suggests
thatmyc is downstream of both rax and pax6, and potentially plays
a role in eye and brain development, and also that myc may be
involved in lens development under the control of pax6.
While disruption of eye development is the most obvious effect
of pax6 mutation in frog embryos/larvae, examination of expres-
sion of a few genes involved with pax6 in regulating regional
forebrain development show that process to be compromised
as well.
Although pax6 function seems to be completely knocked out in
our mutants, in situ hybridization reveals that the mRNA continues
to be expressed throughout most of the normal expression
domains. In the forebrain of late embryonic to larval stages of
Xenopus, pax6 is expressed in the pretectum (prosomere 1), dorsal
thalamus (prosomere 2), prethalamus (prosomere 3) and in the
telencephalon in the lateral and ventral pallium as well as in the
lateral ganglionic eminence (lge) region of the subpallium and in
the olfactory bulbs (Moreno et al., 2008). Interestingly, by stage 38
there is a clear loss of pax6 mRNA from the pretectum and dorsal
thalamus of mutants (Fig. 7A) also seen in mouse mutants
(Mastick et al., 1997), suggesting that Pax6 protein must be
required for continued expression in these regions.
To compare the effects of pax6 mutations in our frog model
with those described in Pax6 mutants in other organisms, we
looked at expression of a small number of genes either known to
be Pax6 targets or whose expression domain overlaps with that of
Pax6.
Nkx2-1 is a homeobox gene that is essential for speciﬁcation of
the basal forebrain structure the medial ganglionic eminence
(mge) (Sussel et al., 1999). In Pax6 homozygous mutant mice,
Nkx2-1 expression expands laterally into the lge (Stoykova et al.,
2000). Similarly, in frog nkx2-1 is expressed in mge as well as the
preoptic area and the hypothalamus (Gonzalez et al., 2002), and
the mge domain appears to be expanded in our mutants (Fig. 7B).
Gsx2 (previously Gsh2) is another homeobox gene expressed in
the developing vertebrate forebrain where, along with Pax6 and
Nkx2-1, it is known to play a key role in regional speciﬁcation. In
mice its primarily subpallial expression domain in the telence-
phalon is largely complementary to the mainly pallial domain of
Pax6, but there is some overlap across the pallial/subpallial
boundary (Yun et al., 2001). That these two genes act together to
establish pallial vs subpallial territories is suggested by the
observations that in Pax6 mutant mice part of the ventral pallium
is respeciﬁed into a structure with characteristics of lge, while in
Gsx2 mutant mice part of the lge is respeciﬁed into tissue with
ventral pallium characteristics (Carney et al., 2009; Yun et al.,
2001). Similarly, in Xenopus gsx2 is expressed in the lge and in the
prethalamus (Illes et al., 2009). Interestingly, when we looked at
stage 41 the telencephalic expression of gsx2 appeared similar in
mutant and wild-type, however the prethalamic expression
domain was missing in the mutants (Fig. 7C).
Lastly, we looked at expression of neurog2, another gene
expressed during forebrain development and shown to be a direct
target of pax6 regulation (Holm et al., 2007; Scardigli et al., 2003).
It is co-expressed in developing cerebral cortex (pallium) in mice,
and its expression is reduced in Pax6 homozygous mutant mice
(Toresson et al., 2000; Yun et al., 2001). In the frog, the tele-
ncephalic (pallial) domain of neurog2 expression appears to be
reduced/missing in the pax6 mutant (Fig. 7D), consistent with
what has been observed in mouse Pax6 mutants.
Although we have looked at only a few gene markers so far, we
ﬁnd alterations in gene expression patterns in the developing
brains of pax6 mutant frogs that are generally consistent with
those predicted for downstream targets of pax6 function and those
reported in Pax6 mutations in other organisms.
Finally, to expand our initial survey of sites of tissues where
pax6 is known to be essential, we looked for evidence of pax6
malfunction in the developing pancreas where we examined
Fig. 6. mab21l1 and myc are downstream of pax6. (A and B) In situ hybridization of wild-type (þ/þ) and pax6 mutant embryos (/ , compound heterozygote of complex1
and 10-kbp inversion mutations, see Table S1 for sequence) at st, 21 (A) or st. 15 (B) with mab21l1 (A) or myc (B) probe. Red arrows indicate expression of mab21l1 (A) and
myc (B) in the eye region. Expression of both genes is reduced in mutants. (C) In situ hybridization of wild-type (þ/?) and rax mutant (/ , see Fish et al., 2014) embryos
with myc probe. Note that myc expression in the presumptive retina region (red arrow) is almost completely lost in the rax mutant as reported previously (Fish et al., 2014),
whereas in the pax6 mutant myc expression is consistently reduced, but to a lesser extent as shown in (B). White dotted circles show the presumptive lens ectoderm (PLE)
region, in which expression of myc is indistinguishable between wild-type and rax mutant embryos. By contrast, expression of myc in the PLE of pax6 mutant is reduced
compared to the wild-type embryo (B, white dotted circles). (D) In situ hybridization of wild-type embryos with pax6 (top left) and myc (top right) probes at stage 15. The
same embryos are bisected at the level shown schematically, clearly showing the expression of pax6 and myc in the PLE (bottom, white dotted circles). (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
T. Nakayama et al. / Developmental Biology 408 (2015) 328–344336
insulin (ins) expression as an indicator of pancreas development,
and as expected its expression was reduced in mutant embryos
(Fig. 8), as has been reported in mouse Pax6mutants (Sander et al.,
1997; St-Onge et al., 1997).
Hypomorphic alleles in combination with “null” alleles cause an eye
phenotype similar to human aniridia
While establishing F1 lines, in one mating between F0 st.716
female #2 and male #3 we found a number of the offspring that
developed into froglets which had a common abnormality, namely
enlarged pupil size. These (total 12) froglets developed from the
apparently wild-type 96 survivors of this mating, i.e. after those
embryos showing the characteristic “null” phenotype (Fig. 4A) died
during tadpole stages. That is, the froglets with the enlarged pupil
phenotype appear to have had no distinctive embryonic phenotype.
Fig. 9 shows typical gross morphological appearance of the mutant
froglets. Genotyping of all 12 frogs (see Table S1) revealed that a
speciﬁc combination of mutations was associated with what we
postulate to be a hypomorphic genotype. All frogs have one allele
with frameshifted mutations that encode truncated proteins lacking
a few amino acids of the end of the paired domain and the rest of C-
terminal portion of the Pax6 protein (as seen in “null” mutants). The
other allele has an in-frame small deletion that deletes a few amino
acids that in almost all cases includes arginine at amino acid 128
(R128), though in one case only amino acid residue 127 is deleted
(see Fig. 9B left panel and Table 1) with the rest of the protein
remaining intact. We hypothesize that this results in production of a
Pax6 protein with reduced activity. We have recently conﬁrmed that
these froglets can survive, and some have reached sexual maturity.
Thus, the features of their eye abnormality and the non-lethality of
this condition are similar to what is seen in human aniridia patients.
Because this mutation results in a phenotype that is signiﬁcantly
less severe than animals with two out-of-frame deletions (which
are presumed to be null), we refer to the compound heterozyg-
otes with an aniridia-like appearance as having a “hypomorphic
phenotype.”
Unlike human aniridia patients who commonly have no visible
iris, all of the hypomorphic mutants have clearly visible, but
substantially reduced iris tissue (Fig. 10). As in human patients,
the eye phenotypes are somewhat variable among individuals and
can even vary between the two eyes of one animal. Examination of
hypomorphic and normal frog eyes revealed that the frog hypo-
morphic mutants show similar abnormalities as seen in humans
including: most commonly, clear lenses (Fig. 10B and F), occasional
focal cataracts (lens opacities) (Fig. 10C and G, white arrows),
frequent peripheral clouding of the cornea (Fig. 10B, C and F,
white arrowheads) and occasional focal losses of remaining iris
tissue (Fig. D and H, red arrows). One hypomorphic mutant frog
appeared to be missing one eye entirely, however upon dissection
a very small rudimentary eye with retinal tissue was found
beneath the skin (not shown).
Fig. 7. pax6 mutants display altered forebrain patterning. In situ hybridization comparison of expression patterns of several genes show altered brain patterns in mutant
versus wild-type embryos. pax6mRNA expression is lost from the pretectum (white arrow) and ventral thalamus of mutants, but appears to be maintained normally in more
anterior parts of the forebrain including retina at stage 38 (A). By contrast, as seen in panel (B) the expression domain of nkx2-1 appears to be expanded in the telecephalon
(white arrow) of pax6 mutants compared to wild-type. gsx2 expression is lost from the prethalamus (C, white arrow) of the mutant, and neurog2 is greatly reduced in the
telencephalon (D, white arrow) of mutant embryos.
Fig. 8. insulin (ins) expression is downregulated in pax6 mutants. Wild-type (left)
and pax6mutant (right) embryos at stage 42 were subjected to in situ hybridization
with an ins probe. Expression of ins gene in this lateral view of mutant embryos
(white arrows) is reduced compared to the level seen in wild-type embryos (orange
arrows). (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
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Since the frog mutants generally retain some iris tissue, we
made measurements of pupil diameter (Fig 10A, white bracket)
and corneal diameter (Fig. 10A, red bracket) in our 12 hypo-
morphic mutants and 12 age-matched, wild-type froglets to better
assess the degree of iris tissue reduction. We found that pupil
diameter was about twice as large in mutant as compared to wild-
type (0.63 70.03 mm vs 0.34 70.02 mm, p¼o0.0001), while the
overall eye size as represented by measurement of the corneal
diameters was about 20% less in mutants compared to wild-type
(1.22 70.03 mm vs 1.46 70.02 mm, po0.0001) (Mean7SEM,
n¼24 wild-type eyes, n¼23 mutant eyes).
Histologic examination of three hypomorphic mutant frog eyes
reveal several key features of the aniridia-like phenotype (Fig. 11) and
permit further comparison with human aniridia and that seen in
heterozygous Pax6 mutant mice (Figs. 12 and 13). In overview, frog
hypomorphic mutant eyes are somewhat smaller than normal, as
indicated by the measurements described above, have lenses that are
also slightly reduced in size (Fig. 11) and show abnormalities in both
ﬁber cells and lens epithelium (Fig. 12). The corneas show abnormal-
ities in layering (Fig. 13), and the irises are consistently reduced
compared with normal (Fig. 11). In general, the hypomorphic eyes
have well developed retinas although they may be folded, and the
ganglion cell layer was sparse and irregular in the cases examined
(Fig. 11), features also seen in some SeyDey mice (Theiler et al., 1978). In
one case the retina was partially missing, but the remainder appeared
normally developed (Fig. 11C).
To examine the phenotype in more detail, histological sections of
the eyes from these animals were compared to wild-type frogs, 8-
week-old wild-type adult mice and siblings heterozygous mutant for
Pax6 (Figs. 12 and 13). Because corneal defects are progressive in both
individuals with aniridia and mice mutant for Pax6, young adult mice
were chosen for these comparisons. The Pax6Sey-Neu/þ mice chosen
for these experiments were on a majority CD1 genetic background to
more closely model the genetics of human aniridia and selected for
more normal eye sizes, again to more closely model human aniridia.
Like mice heterozygous mutant for Pax6, Xenopus harboring the
hypomorphic pax6 genotype had defects in the anterior segment,
which included the cornea, lens and iris. The iris in mutant
animals, while bilayered, was generally reduced in length and
dysmorphic compared to wild-type animals (3 out of 3 hypo-
morphic mutants examined so far). In the most severely affected
mutant examined, iridolenticular and keratolenticular adhesions
were apparent (circle in Fig. 12B). For comparison, iris hypoplasia
was observed in 90% of the mice examined (Fig. 12D″), and
iridokeratotic, iridolenticular and keratolenticular adhesions were
observed in about 30% of the same animals (n¼40). An example of
an iridolenticular adhesion is shown in Fig. 12D0 and iridokeratotic
Fig. 9. Combination of truncated Pax6 protein and Pax6 protein with a small in-
frame deletion causes an aniridia-like phenotype in X. tropicalis froglets. (A) An
example of a heterozygous genotype (left) of phenotypically wild-type froglet
(right). (B) An example of the compound heterozygous genotype (left) of an
aniridia-like froglet (right). All other genotypes of aniridia-like froglets are listed
in Table S1.
Table 1
Pax6 proteins encoded by mutations found in aniridia-like frogs.
Combination of proteins Number of cases (n¼12)
Pax6 (1–126)þadditional 103 amino acids 2
Pax6 (Δ128–130)
Pax6 (1–127)þadditional 103 amino acids 1
Pax6 (Δ128–129)
Pax6 (1–126)þadditional 18 amino acids 1
Pax6 (Δ127)
Pax6 (1–127)þadditional 101 amino acids 2
Pax6 (Δ128–130)
Pax6 (1–126)þadditional 18 amino acids 5a
Pax6 (Δ128–130)
Pax6 (1–125) 1
Pax6 (Δ128–130)
a Their genotypes for in-frame deletions are in two patterns (9-bp deletion and
complex3, see Table S1), but encode the same protein [Pax6 (Δ128–130)].
Fig. 10. Comparison of aniridia-like frog eyes with human aniridic eyes. For
purposes of comparison the images of froglet eyes shown here are approximately
half the size of the human eyes. Actual froglet corneal diameter is approximately
one-tenth that of human. Normal frog (A) and human (E) eyes have small pupil
(indicated by white brackets) and relatively large, pigmented iris. Aniridia-like
mutant froglets (B–D) and human aniridia patients (F–H) show variable eye
phenotypes including reduced (B–D, H) or absent (F and G) iris tissue. Remaining
iris tissue may show focal losses (red arrows D and H). The lenses may be clear (B
and F) or have a focal cataract (white arrows in C and G). Also, both frog and human
eyes may show peripheral clouding of the cornea due to keratopathy (white
arrowheads in B, C and F). (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
T. Nakayama et al. / Developmental Biology 408 (2015) 328–344338
adhesions are denoted with black arrowheads in Fig. 12D. No iris
defects were observed in wild-type littermates (Fig. 12C, n¼40).
Lens defects were comparable between pax6 mutant frogs and
mutant mice, and included cataracts in 16% of frogs (n¼12) and
approximately 67% of the mice (n¼40). In the hypomorphic
Xenopus mutants, the lens epithelium was typically more cuboidal
than the highly ﬂattened epithelium of wild-type frogs (arrow-
heads in Fig.12A0 and B0). Larger epithelial cells are occasionally
observed in the lenses of more severely affected mutant mice (data
not shown).
Most if not all individuals with aniridia will develop a kerato-
pathy known as aniridia-related keratopathy (ARK), which is
caused by a breakdown of the corneal epithelium and invasion
of conjunctival cells (Holland et al., 2003; Mayer et al., 2003;
Netland et al., 2011). To assess the effect of pax6mutations in frogs
compared to mammals, histological sections of cornea were
compared to those from Pax6Sey-Neu/þ mice and the cornea of an
individual with aniridia (Fig. 13). The patient was diagnosed with
stage III keratopathy and had essentially full conjunctivalization of
the cornea (i.e., corneal epithelial cells were largely replaced by
cells from the conjunctiva). The sample here was taken from the
limbal area as a result of a surgical procedure to repair the cornea.
The cornea of the wild-type frog is structurally similar to that of
mouse and human (Fig. 13A, C and E, respectively) and consists of
an outer epithelium, stroma and endothelial layer (Fig. 13A). The
epithelium, which accounts for approximately 10% of the corneal
thickness, consists of a basal layer composed of a single row of
cuboidal to short columnar basal cells, followed by 1–2 layers of
intermediate (wing) cells and one to two layers of ﬂattened
superﬁcial cells. The epithelium is separated from the stroma by
Fig. 11. General histologic features of aniridia-like mutant froglet eyes. Compared with wild-type eyes (A), these mutants show variable defects in cornea, iris, lens and
retina. Most notably, the pupil diameter is much wider in the mutants (B and C). Lenses show variable reduction in size and differentiation consistent with the variable
presence of cataracts visible upon gross inspection of eyes of intact animals. While the retina is usually present and grossly normal, it may contain folds and the ganglion cell
layer (gcl) is somewhat sparse and irregular. The retina may be partially absent as shown in C. Scale bar in panel A¼100 mm.
Fig. 12. Xenopus mutants for pax6 exhibit anterior eye defects comparable to those observed in Pax6 mutant mice. Histological sections cut through eyes from either wild-
type (Normal) or Pax6 mutant (Mutant) X. tropicalis (Xenopus) and mice (Mouse) showing anterior structures. (A) Wild-type froglet eye. White arrowhead denotes lens
epithelial cells. (A0) High magniﬁcation view of lens epithelial cells in region of lens adjacent to retina. Dotted line denotes boundary between lens and retina. (B) pax6
Hypomorphic froglet eye. In addition to the eye being smaller, defects in the cornea, iris, and lens are evident. Circle indicates region with likely iridolenticular adhesion. (B0)
High magniﬁcation view of lens epithelial cells in region of lens adjacent to retina comparable to A0 . Dotted line denotes boundary between lens and retina. Note expansion
of acellular material between lens and retina compared to wild-type. (C) 8-Week-old adult wild-type mouse (D) 8-week-old adult Pax6Sey-Neu/þ mouse. Black arrowheads
denote iridokeratotic adhesion. Open arrowhead denotes iris or ciliary tissues. (D0) Arrow shows iridolenticular adhesion in section cut from different Pax6Sey-Neu/þ mouse.
(D″) Arrow shows iris hypoplasia typically observed in these Pax6Sey-Neu/þ mice; this section was cut from a third Pax6Sey-Neu/þ mouse at a plane comparable to that of the
wild-type mouse in C. cb, ciliary body; nr, neuroretina. Scale bar in panel A applies to panel B; scale bar in C applies to panel D. Scale bars in A0 , B0 and D0 denote 50 μm. Scale
bar in D″ denotes 200 μm.
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an acellular (Bowman’s) layer, which can be difﬁcult to see by light
microscopy. The corneal stroma, which accounts for approximately
90% of the corneal thickness, exhibits a generally well organized,
horizontally arranged laminar appearance with ﬂattened spindle-
shaped keratocytes, and is avascular. A corneal endothelium,
which consists of a single layer of cells, is present on the posterior
surface of the cornea.
Histological analysis of the corneas from pax6 mutant frogs
revealed that, similar to mice and humans heterozygous null for
Pax6 (Fig. 13D and F0, respectively), the corneal epithelium of pax6
hypomorphic frogs appeared to have fewer cell layers and was
generally lacking the more differentiated superﬁcial cells com-
pared to the cornea of wild-type frogs (compare Fig. 13B, B0–A). At
the histological level, whereas basal cells in the wild-type animals
contained round to oval nuclei that stained darkly with toluidine
blue, basal cell nuclei in the mutant corneas tended to be lightly
stained with a punctate appearance. This staining pattern was also
observed in the corneas from Pax6mutant mice using hematoxylin
(compare Fig. 13D–C). Both touidine blue and hematoxylin stain
chromatin. A similar comparison could not be performed on the
aniridia cornea because the normal basal cells were largely absent
from the samples provided (Fig. 13F, data not shown). Rather the
peripheral epithelial layer was composed primarily of cells with a
conjunctival like morphology (Fig. 13F); more centrally (Fig. 13F0),
the aniridic cornea exhibited a thinned and roughened appear-
ance, consistent with a loss of corneal epithelial cells.
In both frogs and mice mutant for Pax6, the anterior stroma
typically contained densely packed and disorganized collagenous
lamella, which had a wavy appearance, and this was similar to the
stroma observed in the cornea from the individual with aniridia
(Fig. 13B, B0, D, F and F0). In contrast with the corneas from mutant
frogs, goblet cells were present in the epithelium of approximately 80%
of Pax6Sey-Neu/þ mice (n¼39) and in the human aniridia sample.
Additionally, blood vessels were observed in the peripheral to mid
anterior stroma in all corneal samples from Pax6Sey-Neu/þ mice (n¼39)
and in the human aniridia sample (arrow in Fig. 13F). Areas of cellular
inﬁltration, indicative of inﬂammatory response, were also observed in
the superﬁcial aniridic corneal stroma (asterisk in Fig. 13F0); similar
inﬁltrations were present in the corneal stroma of the more severely
affected Pax6Sey-Neu/þ mice (data not shown). Both neovascularization
of the cornea and cellular inﬁltration in the stroma are progressive
changes associated with breakdown of corneal epithelium and become
more pronounced with age. Children with aniridia and juvenile Small
eye mice generally have clear corneas without evidence of inappropri-
ate vascularization or evidence of inﬂammation. Therefore, it is likely
that the apparent lack of neovascularization in the corneas of the
Fig. 13. Xenopus pax6 mutant exhibits corneal defects similar to those observed in Pax6mutant mice and human aniridia. Histology of the cornea of wild-type (Normal) and
Pax6mutant (Mutant) frog (Xenopus), mice (Mouse), and human (Human). (A) Wild-type froglet. (B) pax6 Hypomorphic froglet. (C) 8-Week-old adult wild-type mouse (D) 8-
Week-old adult Pax6Sey-Neu/þ mouse. (E) 70-Year-old human. The cornea did not show clinical signs of keratopathy. (F–F0) 49-Year-old individual with classical aniridia. The
patient was diagnosed with stage III keratopathy and exhibited full conjunctivalization of the cornea. Arrow denotes blood vessel. Asterisk denotes area of cellular inﬁltration
in the superﬁcial corneal stroma. The samples here were of peripheral cornea. Note: the endothelial layer was not captured in these images of human cornea. bc, basal cells;
conj, conjunctival cells, sc, superﬁcial cells; wc, wing cells. Scale bar in panel A applies to panels (B–F). (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
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froglets is due to their young age rather than a fundamental difference
in the progression of keratopathy between frogs, mice, and humans.
Discussion
By utilizing gene editing TALENs technology we have generated
an allelic series of mutant lines in the pax6 gene in X. tropicalis that
provide a powerful context for studying pax6 function in devel-
opment and disease, augmenting in signiﬁcant new ways what can
be accomplished with other model organisms. These lines have
already begun to provide valuable new insights about the role of
pax6 gene regulation during development and will continue to be
an important source of clearer understanding about pax6 function
during development.
Generation and phenotypic analysis of out-of-frame exon 7 and 9
pax6 mutations
The mutations that we have generated, while targeted to a
particular locus, are heterogeneous within this locus because the
TALEN technology used here generates different size deletions and
inserts within single embryos at different times and in different
cell lineages. While this approach creates some complexity in
genotyping F0 and F1 animals it also has presented opportunities
to identify a variety of alleles that yielded the different phenotype
outcomes we discuss here. In the future this methodology should
be very valuable in generating other alleles that would permit
novel investigations of Pax6 protein activity, dosage and pheno-
typic effects. We consider here ﬁrst the group of exon 7 and 9 out-
of-frame mutations that lead to a consistent, strong embryonic
phenotype and are likely null mutations.
These mutants highlight the utility of the Xenopus system for
capitalizing on this gene editing technology but generating them
requires careful titration of injected constructs. Targeting genes
essential for development, like pax6, likely implies that one will
generate lethal phenotypes if the mutation rate is high. While one
can reduce the mutation frequency by reducing TALEN concentra-
tions, at a low hit rate, germline transmission is inefﬁcient and
screening of F1 offspring becomes problematic. We ﬁnd that
injecting at relatively high doses, in conjunction with the mosaic
nature of the process, provides the advantage that some animals
have high mutation rates in only some cells, giving rise to
individual animals with a very high germline transmission rate
(up to 100% in a few animals we have generated). As described in
the Results section, with the pax6 gene we can often identify
animals of this kind because one eye will be severely impacted but
not the other. Having animals (particularly males, which can be
mated weekly) carrying such a high level of mutations is clearly
advantageous in generating a high frequency of F1 mutant
embryos for detailed study. This is an especially valuable feature
when one considers the long reproductive lifespan of Xenopus (we
have animals which are 10 years old and still fertile).
The diversity of mutations produced also allowed us to com-
pare phenotypes generated in F1 animals by various mutations. In
this paper we show that putative null mutations toward the end of
the paired domain in exon 7, predicted to be null based on the
target site similarity to mutations in mouse and rat that are
thought to be null (discussed earlier), have a characteristic eye
phenotype (loss of ventral retina and no lens). Mutations in exon 9
(in the pax6 homeodomain), and deletions that include the region
between exon 7 and 9 all have this characteristic phenotype,
suggesting that all of these are likely to be null mutations. In
addition these results imply that the unique transcript generated
from the α promoter, the paired-less form of pax6, Pax6ΔPD,
which would be truncated by the exon 9 deletion within the
homeodomain but remains intact in exon 7 mutations, does not
contribute in a discernable way to early eye development.
As noted in the Introduction, the rationale for proposing that the
mouse Sey mutation is a null and that typical aniridia mutations in
humans are as well (and our mutations in X. tropicalis pax6) come
from the observation that the phenotypes of the mammalian mutants
are indistinguishable from those resulting from deletions spanning the
Pax6 gene. It has also been argued that nonsense mediated decay
(NMD), which is known to cause mRNA degradation in response to
premature stop codon mutations by a well characterized mechanism
(Chang et al., 2007), is responsible for the null phenotype in such PAX6
mutations (e.g. Vincent et al., 2003). Although it has been shown that
NMD machinery exists in Xenopus, at least in oocytes (Whitﬁeld et al.,
1994), we found that pax6 transcripts persist in our mutants based on
in situ hybridization in the tadpole brain (Fig. 7) and at earlier stages as
well (data not shown), even though there is a stop codon shortly
following the mutation site in the 7th exon responsible for the mutant
shown in Fig. 7 as in all exon 7 mutations of this type. Similarly,
mutant Pax6 transcripts are present in mid-gestation mouse embryos
homozygous mutant for the SeyNeu allele (Pax6Sey-Neu/Sey-Neu) at levels
comparable to wildtype Pax6 (Mastick et al., 1997; and Lauderdale,
unpublished). In addition, another study on a premature stop codon
mutation in Xenopus, in this case the eye regulatory gene rax (Fish
et al., 2014) also shows embryonic expression of the mutant RNA.
Within the nervous system there is also evidence that a microRNA,
miR-128, inhibits NMD in embryos of several vertebrates, including
Xenopus (Bruno et al., 2011). We have preliminary evidence (Qiu,
Nakayama and Grainger, unpublished) that this microRNA is expressed
in the embryonic eye, brain and neural tube. All of this data together
with recent reports suggesting that NMD is not a universal phenom-
enon in stop codon mutations (e.g. Neu-Yilik et al., 2011) argue that
NMD is not a primary mechanism for regulating expression of
premature stop codon mutants in pax6 and possibly more broadly in
embryogenesis.
If we accept the hypothesis that pax6 mutations in exon 7 and
exon 9 are null, we would invoke the proposal discussed earlier that
pax6.2 plays a role in mitigating the degree of the retinal phenotype
in our mutants. We have already used CRISPR-mediated gene
targeting to mutate the pax6.2 and are currently raising animals to
evaluate the contribution of this gene to eye development. It has
been shown that in zebraﬁsh, an antisense morpholino oligonucleo-
tide directed against pax6.2 does reduce eye size in wild-type
embryos (Ravi et al., 2013). Our analysis of expression of pax6.2 is
consistent with a role in retinal phenotype in the pax6 mutant
because, as noted earlier, expression is restricted to the dorsal retina
(which persists in the mutant), but also we note that pax6.2 is not
expressed in the lens, and that the lens is completely absent in the
pax6 mutant. In addition pax6.2 is not expressed early in develop-
ment, nor in the brain and the alterations we see in expression of
genes likemyc andmab21l1 in the early retina (Fig. 6) and brain later
(Fig. 7) are consistent with a null phenotype in these domains of pax6
activity. The signiﬁcant effect of pax6.2 on retina formation is some-
what surprising given its late onset of expression.
pax6 Gene targets in putative null mutants
We report here some preliminary ﬁndings about expression of
putative gene targets of pax6 that both highlight new observati-
ons and the gaps in our understanding of pax6 regulation of
patterning. As noted in the Introduction, there are few studies of
the earliest pax6 targets, likely to be a group of genes that would
be highly informative about the primary roles of this gene both in
development and disease. In our work we have shown, as in
mammals, that the nuclear protein gene mab21l1 is highly reduced
in the eye region in our putative pax6 null embryos. Gene targeting
of mab21l1 in mice reveals that this gene is essential for lens
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formation (Yamada et al., 2003) and a future area of interest will
be to ascertain the extent to which the failure of the lens to form in
the pax6 mutant is related to its effect on mab21l1 expression.
Because the myc gene is expressed in a large part of the early
pax6-expressing domain and is so important in pluripotency and
maintaining progenitor cells in a number of developmental con-
texts (Prasad et al., 2012; Smith and Dalton, 2010), roles which ﬁt
within the framework of pax6 function in pluripotency regulation
and neurogenesis (e.g. Sansom et al., 2009), we decided to
examine the expression of myc at the neural plate stage, shortly
after pax6 activation. Previously, we found myc to be down-
regulated in another key eye gene required for retina speciﬁcation,
rax (Fish et al., 2014). As shown in Fig. 6 myc is indeed down-
regulated in the retina, and in the lens ectoderm as well, implying
a potentially important role in both of these components of the
eye. In other studies, targeted downregulation of the myc gene by
morpholino antisense oligonucleotide injection into the blasto-
meres giving rise to the head region in Xenopus laevis embryos is
shown to interfere with eye development (Bellmeyer et al., 2003).
A recent study also highlights the role of Myc in cell proliferation
during mouse lens development (Cavalheiro et al., 2014). Further
studies on the function of myc as a potential mediator of pax6
activity will be an important goal for the future. A more thorough
study of putative gene targets by RNA-Seq analysis, as was
performed in our rax mutant study in X. tropicalis (Fish et al.,
2014), will be instrumental in elucidating the core genes involved
in the eye and neural gene regulatory network involved in the
speciﬁcation events that occur by the neural plate stage (Saha and
Grainger, 1992).
Preliminary examinations of expression of putative pax6 targets
in the brain and pancreas are also informative. In the work
presented here we see expression of several key brain regulators
that have been shown to be pax6 targets in previous studies and
ﬁnd that they modulate gene expression in ways similar to those
seen in mammals, illustrating the requirement for positive feed-
back to maintain Pax6 expression in some regions of the dience-
phalon (Mastick et al., 1997) and substantiating its role in dorsal/
ventral patterning in the forebrain (Georgala et al., 2011). How-
ever, as discussed above, the role of pax6 in initial patterning
events remains largely unexamined, though Xenopus appears to
preserve many of the brain functions of Pax6 in mammals and
again should serve as a valuable model for examining these early
events. Turning to the activity of pax6 in the pancreas, again our
data on insulin in the pax6 mutant Xenopus indicates the con-
servation of function in this organ as well, as reported elsewhere
(Pearl et al., 2009).
Hypomorphic mutations in pax6 lead to an aniridia-like phenotype
The genetic lesions that do not lead to obvious embryonic
phenotypes, but elicit an aniridia-like phenotype in froglets, reveal
further important features of the TALEN-mediated mutations in
X. tropicalis. As background information, we note that animals
carrying heterozygous mutations that we believe are null (e.g.
frameshift mutations in exon 7) have no obvious eye phenotype,
whereas in mammals mutations of this kind would yield an
aniridia phenotype. This may suggest a compensatory role of the
pax6.2 gene. In addition it is also possible that the activity of pax6
itself, or the genetic context in Xenopus differs slightly from that in
mammals. It is known that in mice eye development is adversely
affected by modest changes (either reductions or increases) in the
level of Pax6 (Schedl et al., 1996). While raising F1 froglets with
complex genotypes we noticed some which developed aniridia
and it was at this point that we ascertained that animals carrying
one putative null allele and one allele with a small in-frame
deletion might be hypomorphs, which are likely to have less than
one-half of the wild-type level of Pax6 activity. As noted in the
Results section, all of the animals with the hypomorphic pheno-
type include deletions at or adjacent to amino acid 128, a
conserved paired domain residue that causes aniridia in a number
of patients as a result of missense mutations and which contacts
the major groove of DNA (van Heyningen and Williamson, 2002).
These results highlighted to us a previously unappreciated poten-
tial value of small in-frame deletions in helping to pinpoint key
regions associated with a particular gene function. In the future we
intend to identify this kind of lesion in targeted regions of the pax6
gene outside of the paired domain (where most aniridia-causing
mutations are found). As pointed out by others (van Heyningen
and Williamson, 2002), while most of the human mutations in
PAX6 that have been identiﬁed affect the eye, this ﬁnding may be a
product of observational bias, as generally only patients presenting
with eye-related diseases would be likely to have their PAX6 locus
sequenced. Further identiﬁcation of vertebrate model phenotypes
in other tissues where pax6 is expressed, and which are caused by
pax6 mutant alleles with lesions in other key regions of the
protein, may reveal novel connections to human disease.
Importantly, we show for the ﬁrst time that mutations in the
Pax6 gene cause similar anterior eye defects in both amphibians
and mammals. The structures of the anterior segment of the
vertebrate eye, which include the cornea, iris, ciliary body, and
lens, are required to focus the light that enters the eye and to
regulate intraocular pressure. Developmental defects of these
structures can lead to several debilitating eye diseases, including
cataracts, corneal dystrophies, and glaucoma. Despite much work
in rodent models over the past several decades, a detailed under-
standing of the molecular mechanisms and genetic hierarchies
involved in anterior segment formation is still lacking. Our results
demonstrate that, at least in the case of Pax6, the mechanisms
controlling these processes have been conserved between
humans, rodents, and X. tropicalis, which last shared a common
ancestor approximately 350 million years ago (Hedges and Kumar,
2002), and demonstrate Xenopus as an important new vertebrate
model for investigations addressing eye problems of signiﬁcant
interest to human health.
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